These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34261348)

  • 21. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents.
    Cobry EC; Hamburger E; Jaser SS
    Diabetes Technol Ther; 2020 Nov; 22(11):794-800. PubMed ID: 32212971
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2014 Jun; 11(6):943-55. PubMed ID: 24749563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.
    Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Ghatak A; Randell T; Besser REJ; Trevelyan N; Hovorka R; Lawton J
    Diabetes Technol Ther; 2020 Jun; 22(6):468-475. PubMed ID: 32048877
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.
    Hovorka R; Kumareswaran K; Harris J; Allen JM; Elleri D; Xing D; Kollman C; Nodale M; Murphy HR; Dunger DB; Amiel SA; Heller SR; Wilinska ME; Evans ML
    BMJ; 2011 Apr; 342():d1855. PubMed ID: 21493665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adolescents with type 1 diabetes vs. hybrid closed loop systems: a case series of patients' behaviour that challenges the algorithm.
    Zanfardino A; Piscopo A; Gizzone P; Vitulano C; Di Gennaro F; Buccella G; Fabozzi I; Mainolfi G; Marongiu MB; Rollato AS; Testa V; Chianese A; Miraglia Del Giudice E; Troncone A; Iafusco D
    J Pediatr Endocrinol Metab; 2023 Feb; 36(2):216-222. PubMed ID: 36511758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
    Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R
    Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.
    Lawton J; Blackburn M; Rankin D; Werner C; Farrington C; Hovorka R; Hallowell N
    AJOB Empir Bioeth; 2019; 10(2):100-112. PubMed ID: 30986113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study.
    Lawton J; Rankin D; Hartnell S; Lee T; Dover AR; Reynolds RM; Hovorka R; Murphy HR; Hart RI;
    Diabet Med; 2023 May; 40(5):e15072. PubMed ID: 36807582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes.
    O'Grady MJ; Retterath AJ; Keenan DB; Kurtz N; Cantwell M; Spital G; Kremliovsky MN; Roy A; Davis EA; Jones TW; Ly TT
    Diabetes Care; 2012 Nov; 35(11):2182-7. PubMed ID: 22875230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Closed-loop in children with type 1 diabetes: specific challenges.
    Elleri D; Allen JM; Dunger DB; Hovorkea R
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S131-5. PubMed ID: 21864745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    Boughton CK; Allen JM; Ware J; Wilinska ME; Hartnell S; Thankamony A; Randell T; Ghatak A; Besser REJ; Elleri D; Trevelyan N; Campbell FM; Sibayan J; Calhoun P; Bailey R; Dunseath G; Hovorka R;
    N Engl J Med; 2022 Sep; 387(10):882-893. PubMed ID: 36069870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Patient Experience of Long-Term Hybrid Closed-Loop Insulin Pump Use.
    Wang LR; Malcolm J; Arnaout A; Humphrey-Murto S; LaDonna KA
    Can J Diabetes; 2021 Dec; 45(8):750-756.e3. PubMed ID: 33958309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series.
    Daly A; Hartnell S; Boughton CK; Evans M
    J Diabetes Sci Technol; 2021 Nov; 15(6):1216-1223. PubMed ID: 34378426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial.
    Kudva YC; Laffel LM; Brown SA; Raghinaru D; Pinsker JE; Ekhlaspour L; Levy CJ; Messer LH; Kovatchev BP; Lum JW; Beck RW; Gonder-Frederick L;
    Diabetes Technol Ther; 2021 Oct; 23(10):673-683. PubMed ID: 34115959
    [No Abstract]   [Full Text] [Related]  

  • 39. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.